Paul Jurasz
Impact in
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
- Hematology top 2%
- Platelet Disorders and Treatments
Papers in
- Hematology 22
- Platelet Disorders and Treatments 16
- Blood Coagulation and Thrombosis Mechanisms 7
-
- Protease and Inhibitor Mechanisms 12
- Co-authors
- Marek W. Radomski (18 shared papers)David Alonso‐Escolano (4 shared papers)Anna Radomski (6 shared papers)Marek Radomski (3 shared papers)Mengjie Yan (3 shared papers)Tadeusz Maliñski (2 shared papers)Maria T. Morandi (1 shared paper)Maria José Santos-Martínez (6 shared papers)
- Journals
- British Journal of Pharmacology (7 papers)Journal of Thrombosis and Haemostasis (5 papers)Thrombosis Research (5 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)The FASEB Journal (2 papers)
- Partner nations
- CanadaUnited StatesIreland
In The Last Decade
Paul Jurasz
49 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 134
- Internal Medicine 201
- Hematology 571
- Biological Psychiatry 82
- Cancer Research 434
- Oncology 633
Countries citing papers authored by Paul Jurasz
This map shows the geographic impact of Paul Jurasz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Jurasz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Jurasz more than expected).
Fields of papers citing papers by Paul Jurasz
This network shows the impact of papers produced by Paul Jurasz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Jurasz. The network helps show where Paul Jurasz may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Jurasz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 446 | |
| 2 | 2004 | 273 | |
| 3 | 2015 | 150 | |
| 4 | 2004 | 148 | |
| 5 | Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide. | 2001 | 110 |
| 6 | 2007 | 104 | |
| 7 | 2010 | 103 | |
| 8 | 2005 | 76 | |
| 9 | 2006 | 64 | |
| 10 | 2002 | 64 | |
| 11 | 2002 | 64 | |
| 12 | 2013 | 53 | |
| 13 | 2008 | 51 | |
| 14 | 2017 | 50 | |
| 15 | 2003 | 48 | |
| 16 | 2004 | 47 | |
| 17 | 2016 | 44 | |
| 18 | 2006 | 41 | |
| 19 | 2016 | 40 | |
| 20 | 2006 | 39 |
About Paul Jurasz
Paul Jurasz is a scholar working on Hematology, Cancer Research, Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine, having authored 51 papers that have together received 2.5k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (16 papers), Protease and Inhibitor Mechanisms (12 papers), Inflammatory Biomarkers in Disease Prognosis (10 papers), Angiogenesis and VEGF in Cancer (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers), Nitric Oxide and Endothelin Effects (6 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). The work is most often cited by research in Internal Medicine (201 citations), Hematology (571 citations), Biological Psychiatry (82 citations), Cancer Research (434 citations) and Oncology (633 citations). Paul Jurasz has collaborated with scholars based in Canada, United States and Ireland. Frequent co-authors include Marek W. Radomski, David Alonso‐Escolano, Anna Radomski, Marek Radomski, Mengjie Yan, Tadeusz Maliñski, Maria T. Morandi, Maria José Santos-Martínez, Aneta Radziwon‐Balicka and Carlos Medina. Their work appears in journals such as British Journal of Pharmacology, Journal of Thrombosis and Haemostasis, Thrombosis Research, Journal of Pharmacology and Experimental Therapeutics and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.